BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 12878741)

  • 21. Aortic stenosis, von Willebrand factor, and bleeding.
    Williams RC
    N Engl J Med; 2003 Oct; 349(18):1773-4; author reply 1773-4. PubMed ID: 14593996
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of transcutaneous aortic valve implantation on the Heyde's syndrome.
    Benton SM; Kumar A; Crenshaw M; Fredi JL
    Am J Cardiol; 2014 Sep; 114(6):953-4. PubMed ID: 25208564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalent platelet dysfunction in patients with aortic valve disease.
    Prohaska W; Zittermann A; Lüth JU; Inoue K; Köster-Eiserfunke W; Baller D; Körfer R; Kleesiek K
    J Heart Valve Dis; 2008 Sep; 17(5):542-7. PubMed ID: 18980088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
    Uriel N; Pak SW; Jorde UP; Jude B; Susen S; Vincentelli A; Ennezat PV; Cappleman S; Naka Y; Mancini D
    J Am Coll Cardiol; 2010 Oct; 56(15):1207-13. PubMed ID: 20598466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of Heyde's syndrome by abnormal closure times despite normal von Willebrand's activity.
    D'Souza PM; Blostein MD
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):622-3. PubMed ID: 21760480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unexpectedly High Prevalence of Acquired von Willebrand Syndrome in Patients with Severe Aortic Stenosis as Evaluated with a Novel Large Multimer Index.
    Tamura T; Horiuchi H; Imai M; Tada T; Shiomi H; Kuroda M; Nishimura S; Takahashi Y; Yoshikawa Y; Tsujimura A; Amano M; Hayama Y; Imamura S; Onishi N; Tamaki Y; Enomoto S; Miyake M; Kondo H; Kaitani K; Izumi C; Kimura T; Nakagawa Y
    J Atheroscler Thromb; 2015; 22(11):1115-23. PubMed ID: 26269004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
    Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis.
    Natorska J; Bykowska K; Hlawaty M; Marek G; Sadowski J; Undas A
    Heart; 2011 Dec; 97(24):2023-8. PubMed ID: 21561895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of valve prosthesis-patient mismatch on long-term survival and left ventricular mass regression after aortic valve replacement for aortic stenosis.
    Kato Y; Suehiro S; Shibata T; Sasaki Y; Hirai H
    J Card Surg; 2007; 22(4):314-9. PubMed ID: 17661773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients.
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Trummer G; Berchtold-Herz M; Schlensak C; Zieger B
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1328-33; discussion 1233. PubMed ID: 21515067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation.
    Marggraf O; Schneppenheim S; Daubmann A; Budde U; Seiffert M; Reichenspurner H; Treede H; Blankenberg S; Diemert P
    J Invasive Cardiol; 2014 Dec; 26(12):654-8. PubMed ID: 25480995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Von Willebrand's disease following aortic valve replacement.
    Singh S; Klarich K; Beckman T
    J Heart Valve Dis; 2012 May; 21(3):405-6. PubMed ID: 22808848
    [No Abstract]   [Full Text] [Related]  

  • 34. Severe Aortic Valve Stenosis.
    Frank RD; Lanzmich R; Haager PK; Budde U
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):229-234. PubMed ID: 27481874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
    Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe aortic valve stenosis and nosebleed.
    Schödel J; Obergfell A; Maass AH
    Int J Cardiol; 2007 Aug; 120(2):286-7. PubMed ID: 17150267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcatheter aortic valve implantation leads to a restoration of von Willebrand factor (VWF) abnormalities in patients with severe aortic stenosis - Incidence and relevance of clinical and subclinical VWF dysfunction in patients undergoing transfemoral TAVI.
    Sedaghat A; Kulka H; Sinning JM; Falkenberg N; Driesen J; Preisler B; Hammerstingl C; Nickenig G; Pötzsch B; Oldenburg J; Hertfelder HJ; Werner N
    Thromb Res; 2017 Mar; 151():23-28. PubMed ID: 28088607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired von Willebrand syndrome and mitral valve prosthesis leakage. A pilot study.
    Pérez-Rodríguez A; Pinto JC; Lourés E; Rodríguez-Trillo A; Cuenca JJ; Batlle J; López-Fernández MF
    Eur J Haematol; 2011 Nov; 87(5):448-56. PubMed ID: 21668503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of loss of high-molecular-weight von Willebrand factor multimers on blood loss after aortic valve replacement.
    Bolliger D; Dell-Kuster S; Seeberger MD; Tanaka KA; Gregor M; Zenklusen U; Tsakiris DA; Filipovic M
    Br J Anaesth; 2012 May; 108(5):754-62. PubMed ID: 22311365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.
    Bander J; Elmariah S; Aledort LM; Dlott J; Stelzer P; Halperin JL; Kini AS; Sharma SK
    Thromb Haemost; 2012 Jul; 108(1):86-93. PubMed ID: 22627470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.